GB9601666D0
(en)
*
|
1996-01-27 |
1996-03-27 |
Zeneca Ltd |
Chemical compounds
|
GB9702213D0
(en)
*
|
1996-02-24 |
1997-03-26 |
Zeneca Ltd |
Chemical compounds
|
GB9609919D0
(en)
|
1996-05-11 |
1996-07-17 |
Zeneca Ltd |
Chemical compounds
|
GB9717807D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
US7002020B1
(en)
|
1998-01-23 |
2006-02-21 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
US6562844B2
(en)
|
1998-01-23 |
2003-05-13 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
EP1049682A1
(fr)
|
1998-01-23 |
2000-11-08 |
Versicor, Inc. |
Banques combinatoires d'oxazolidinones, compositions a base de tels composes et procedes de preparation
|
IL140084A0
(en)
|
1998-06-05 |
2002-02-10 |
Astra Ab |
Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
DE19958153A1
(de)
*
|
1999-12-03 |
2001-06-07 |
Yamanouchi Pharma Co Ltd |
Oxazolidinon-Derivate
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
GB0009803D0
(en)
|
2000-04-25 |
2000-06-07 |
Astrazeneca Ab |
Chemical compounds
|
WO2003008389A1
(fr)
*
|
2001-07-16 |
2003-01-30 |
Ranbaxy Laboratories Limited |
Derives d'oxazolidinone utilises comme antimicrobiens potentiels
|
US6734307B2
(en)
*
|
2000-07-17 |
2004-05-11 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
DE60118241T2
(de)
|
2000-10-17 |
2006-12-28 |
Pharmacia & Upjohn Co. Llc, Kalamazoo |
Verfahren zur herstellung von oxazolidinonverbindungen
|
US7160912B2
(en)
*
|
2000-12-26 |
2007-01-09 |
Dr.Reddy's Laboratories Ltd. |
Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
|
SE0100326D0
(sv)
|
2001-02-02 |
2001-02-02 |
Astrazeneca Ab |
New compounds
|
JP2004518724A
(ja)
*
|
2001-02-07 |
2004-06-24 |
オーソーマクニール ファーマシューティカル, インコーポレイテッド |
ピリドアリールフェニル・オキサゾリジノン抗菌剤、および関連の組成物および方法
|
EP1379509A1
(fr)
|
2001-04-20 |
2004-01-14 |
PHARMACIA & UPJOHN COMPANY |
Procede de preparation d'oxazolidinones
|
DE10129725A1
(de)
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
US6956040B2
(en)
*
|
2001-07-16 |
2005-10-18 |
Ranbaxy Laboratories Limited |
Oxazolidinone piperazinyl derivatives as potential antimicrobials
|
PL373802A1
(en)
*
|
2002-05-15 |
2005-09-19 |
Ranbaxy Laboratories Limited |
Polymorphic forms of phenyl oxazolidinone derivatives
|
EP1539745B1
(fr)
|
2002-08-12 |
2006-03-29 |
Pharmacia & Upjohn Company LLC |
N-aryl-2-oxazolidinones et leurs derives
|
WO2004026848A1
(fr)
|
2002-09-20 |
2004-04-01 |
Lupin Limited |
Derives d'oxazolidinone, leur procede de preparation et leur utilisation comme agents antimycobacterients
|
US7141570B2
(en)
|
2002-11-21 |
2006-11-28 |
Pharmacia & Upjohn Company |
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
|
DE10300111A1
(de)
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
US7687627B2
(en)
*
|
2003-09-08 |
2010-03-30 |
Wockhardt Limited |
Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
US7715789B2
(en)
*
|
2005-01-20 |
2010-05-11 |
Song park |
Method and apparatus mechanically providing and/or using modulated audio effects into the interior of human flesh
|
EP1685841A1
(fr)
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prevention et traitement de troubles thromboemboliques
|
WO2007004049A1
(fr)
*
|
2005-07-06 |
2007-01-11 |
Pharmacia & Upjohn Company Llc |
Oxazolidinones contenant de l'azétidine comme agents antibactériens
|
DE102005045518A1
(de)
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
SG166126A1
(en)
|
2005-10-04 |
2010-11-29 |
Bayer Schering Pharma Ag |
Novel polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo- 3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
|
KR20080110877A
(ko)
|
2006-03-31 |
2008-12-19 |
재단법인 이쯔우 연구소 |
헤테로환을 갖는 신규 화합물
|
US8841334B2
(en)
|
2006-05-31 |
2014-09-23 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands and uses thereof
|
CA2647598A1
(fr)
|
2006-05-31 |
2007-12-06 |
Abbott Laboratories |
Nouveaux composes constituant des ligands de recepteurs cannabinoides et utilisations de ces composes
|
MX2008015217A
(es)
|
2006-05-31 |
2008-12-12 |
Abbott Lab |
Compuestos de tiazol como ligandos del receptor de canabinoides y usos de los mismos.
|
US20080139563A1
(en)
*
|
2006-10-23 |
2008-06-12 |
Concert Pharmaceuticals Inc. |
Oxazolidinone derivatives and methods of use
|
US8796267B2
(en)
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
AU2008226947B2
(en)
|
2007-03-08 |
2014-07-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
|
MX2009010363A
(es)
|
2007-03-28 |
2009-12-04 |
Abbott Lab |
Compuestos de 1,3-tiazol-2(3h)-ilideno como ligandos del receptor canabinoide.
|
US8501794B2
(en)
|
2007-04-17 |
2013-08-06 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
US7872033B2
(en)
|
2007-04-17 |
2011-01-18 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
DE102007018662A1
(de)
|
2007-04-20 |
2008-10-23 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie
|
MX2009012374A
(es)
|
2007-05-18 |
2009-12-01 |
Abbott Lab |
Compuestos novedosos como ligandos del receptor de canabinoides.
|
DE102007028318A1
(de)
|
2007-06-20 |
2008-12-24 |
Bayer Healthcare Ag |
Oxazolidinone zur Behandlung und Prophylaxe von Sepsis
|
CN101883768A
(zh)
|
2007-10-02 |
2010-11-10 |
财团法人乙卯研究所 |
具有7元杂环的噁唑烷酮衍生物
|
US9193713B2
(en)
|
2007-10-12 |
2015-11-24 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
EP2274306A1
(fr)
|
2008-03-11 |
2011-01-19 |
Abbott Laboratories |
Nouveaux composés en tant que ligands du récepteur de cannabinoïde
|
US8653100B2
(en)
|
2008-04-01 |
2014-02-18 |
Abbvie Inc. |
Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
|
US8354557B2
(en)
*
|
2008-06-17 |
2013-01-15 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated morpholine derivatives
|
EP2138178A1
(fr)
|
2008-06-28 |
2009-12-30 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidinones pour le traitement de maladie pulmonaire obstructive chronique (MPOC) et/ou de l'asthme
|
EP2140866A1
(fr)
|
2008-07-04 |
2010-01-06 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidinones pour le traitement d'états inflammatoires du tractus gastro-intestinal
|
EP2331516B1
(fr)
|
2008-08-15 |
2013-03-13 |
Abbott Laboratories |
Dérivés imine comme ligands de récepteurs de cannabinoïdes
|
US8354435B2
(en)
*
|
2008-09-08 |
2013-01-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulators of aldehyde dehydrogenase activity and methods of use thereof
|
US8846730B2
(en)
|
2008-09-08 |
2014-09-30 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
JP2012502917A
(ja)
|
2008-09-16 |
2012-02-02 |
アボット・ラボラトリーズ |
カンナビノイド受容体リガンドとしての置換ベンズアミド類
|
US8604053B2
(en)
|
2008-10-17 |
2013-12-10 |
Abbvie Inc. |
TRPV1 antagonists
|
JP2012505908A
(ja)
|
2008-10-17 |
2012-03-08 |
アボット・ラボラトリーズ |
Trpv1アンタゴニスト
|
JP2012506856A
(ja)
|
2008-10-28 |
2012-03-22 |
ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
アルデヒドデヒドロゲナーゼのモジュレーターおよびその使用方法
|
US20100160322A1
(en)
|
2008-12-04 |
2010-06-24 |
Abbott Laboratories |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
UA108193C2
(uk)
|
2008-12-04 |
2015-04-10 |
|
Апоптозіндукуючий засіб для лікування раку і імунних і аутоімунних захворювань
|
US8557983B2
(en)
|
2008-12-04 |
2013-10-15 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US8563735B2
(en)
|
2008-12-05 |
2013-10-22 |
Abbvie Inc. |
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
|
US8586754B2
(en)
|
2008-12-05 |
2013-11-19 |
Abbvie Inc. |
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
|
EP3666758A1
(fr)
|
2008-12-05 |
2020-06-17 |
AbbVie Inc. |
Procédé de préparation d`un dérivé de sulfonamide
|
PA8854001A1
(es)
|
2008-12-16 |
2010-07-27 |
Abbott Lab |
Compuestos novedosos como ligandos de receptores de canabinoides
|
AU2010204555B2
(en)
|
2009-01-19 |
2013-03-07 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
NZ616828A
(en)
|
2009-01-19 |
2015-03-27 |
Abbvie Inc |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
AR075442A1
(es)
|
2009-02-16 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
|
TWI519530B
(zh)
|
2009-02-20 |
2016-02-01 |
艾伯維德國有限及兩合公司 |
羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途
|
US8288428B2
(en)
|
2009-03-27 |
2012-10-16 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
EP2851366A1
(fr)
|
2009-03-27 |
2015-03-25 |
Abbvie Inc. |
Composés en tant que ligands du récepteur cannabinoïde
|
EP2411371B1
(fr)
|
2009-03-27 |
2015-05-20 |
AbbVie Inc. |
Composes en tant que ligands des recepteurs cannabinoïdes
|
US8841296B2
(en)
*
|
2009-03-27 |
2014-09-23 |
Council of Scientific and Industrial Research, Anusandhan Bhawan, Rafi Marg |
Substituted 1, 4-dioxa-8-azaspiro[4,5]decanes useful as fungicides and a process for the preparation thereof
|
US8507493B2
(en)
|
2009-04-20 |
2013-08-13 |
Abbvie Inc. |
Amide and amidine derivatives and uses thereof
|
US8236798B2
(en)
|
2009-05-07 |
2012-08-07 |
Abbott Gmbh & Co. Kg |
Carboxamide compounds and their use as calpain inhibitors
|
US8546399B2
(en)
|
2009-05-26 |
2013-10-01 |
Abbvie Inc. |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US20220315555A1
(en)
|
2009-05-26 |
2022-10-06 |
Abbvie Inc. |
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US9034875B2
(en)
|
2009-05-26 |
2015-05-19 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
DK2435432T6
(da)
|
2009-05-26 |
2023-12-18 |
Abbvie Ireland Unlimited Co |
Apoptose-inducerende midler til behandling af cancer og immune og autoimmune sygdomme
|
WO2010138828A2
(fr)
|
2009-05-29 |
2010-12-02 |
Abbott Laboratories |
Modulateurs des canaux potassiques
|
WO2011053740A1
(fr)
|
2009-10-28 |
2011-05-05 |
Belkin International, Inc. |
Boîtier protecteur de dispositif de communication multimédia portatif, et procédé de fabrication de ce boîtier
|
US8629143B2
(en)
|
2009-11-25 |
2014-01-14 |
Abbvie Inc. |
Potassium channel modulators
|
TW201130855A
(en)
|
2009-12-16 |
2011-09-16 |
Abbott Lab |
Prodrug compounds useful as cannabinoid ligands
|
RU2568611C2
(ru)
|
2010-03-25 |
2015-11-20 |
Эббви Инк. |
Средства, индуцирующие апоптоз, для лечения рака, иммунных и аутоиммунных заболеваний
|
TWI520960B
(zh)
|
2010-05-26 |
2016-02-11 |
艾伯維有限公司 |
用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘導劑
|
US8586596B2
(en)
|
2010-06-15 |
2013-11-19 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
SG187811A1
(en)
|
2010-08-10 |
2013-03-28 |
Abbvie Inc |
Novel trpv3 modulators
|
US9045459B2
(en)
|
2010-08-13 |
2015-06-02 |
AbbVie Deutschland GmbH & Co. KG |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8877794B2
(en)
|
2010-08-13 |
2014-11-04 |
Abbott Laboratories |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2012041814A1
(fr)
|
2010-09-27 |
2012-04-05 |
Abbott Gmbh & Co. Kg |
Composés hétérocycliques et leur utilisation en tant qu'inhibiteurs de la glycogène synthase kinase-3
|
CA2811805A1
(fr)
|
2010-10-29 |
2012-05-03 |
Abbvie Inc. |
Dispersions solides contenant un agent induisant l'apoptose
|
UA113500C2
(xx)
|
2010-10-29 |
2017-02-10 |
|
Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
|
WO2012059431A1
(fr)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Composés de type benzènesulfonyle ou sulfonamide appropriés pour le traitement de troubles qui répondent à la modulation du récepteur 5-ht6 de la sérotonine
|
WO2012059432A1
(fr)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Composés de type n-phényl-(homo)pipérazinyl-benzènesulfonyle ou benzènesulfonamide appropriés pour le traitement de troubles qui répondent à la modulation du récepteur 5-ht6
|
TW201238950A
(en)
|
2010-11-15 |
2012-10-01 |
Abbott Lab |
NAMPT and rock inhibitors
|
CA2817093A1
(fr)
|
2010-11-15 |
2012-05-24 |
Abbvie Inc. |
Inhibiteurs de nampt
|
WO2012067824A1
(fr)
|
2010-11-16 |
2012-05-24 |
Abbott Laboratories |
Modulateurs des canaux potassiques
|
US8609669B2
(en)
|
2010-11-16 |
2013-12-17 |
Abbvie Inc. |
Potassium channel modulators
|
KR101923364B1
(ko)
|
2010-11-23 |
2018-11-30 |
애브비 인코포레이티드 |
아폽토시스유도제의 염 및 결정형
|
DK2642999T3
(en)
|
2010-11-23 |
2017-01-09 |
Abbvie Ireland Unlimited Co |
METHODS OF TREATMENT FOR USING selectivity-VE BCL-2 INHIBITORS
|
WO2012082992A1
(fr)
*
|
2010-12-15 |
2012-06-21 |
Biovista, Inc. |
Compositions et procédés pour le traitement du cancer
|
US9090592B2
(en)
|
2010-12-30 |
2015-07-28 |
AbbVie Deutschland GmbH & Co. KG |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
US8802693B1
(en)
|
2011-03-09 |
2014-08-12 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
US9012651B2
(en)
|
2011-03-24 |
2015-04-21 |
Abbvie Inc. |
TRPV3 modulators
|
TW201302681A
(zh)
|
2011-03-25 |
2013-01-16 |
Abbott Lab |
Trpv1拮抗劑
|
WO2012149106A1
(fr)
|
2011-04-29 |
2012-11-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions et procédés d'augmentation de la prolifération de cellules souches salivaires adultes
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8859549B2
(en)
|
2011-05-13 |
2014-10-14 |
Abbvie, Inc. |
Potassium channel modulators
|
WO2013020930A1
(fr)
|
2011-08-05 |
2013-02-14 |
Abbott Gmbh & Co. Kg |
Dérivés d'aminochromane, d'aminothiochromane et d'amino-1,2,3,4-tétrahydroquinoléine, compositions pharmaceutiques contenant ceux-ci et leur utilisation thérapeutique
|
TWI571466B
(zh)
|
2011-10-14 |
2017-02-21 |
艾伯維有限公司 |
用於治療癌症及免疫與自體免疫疾病之細胞凋亡誘發劑
|
TWI561521B
(en)
|
2011-10-14 |
2016-12-11 |
Abbvie Inc |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
WO2013062966A2
(fr)
|
2011-10-24 |
2013-05-02 |
Abbvie Inc. |
Nouveaux modulateurs de trpv3
|
US20130116241A1
(en)
|
2011-11-09 |
2013-05-09 |
Abbvie Inc. |
Novel inhibitor compounds of phosphodiesterase type 10a
|
JP2014533675A
(ja)
|
2011-11-18 |
2014-12-15 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
N置換アミノベンゾシクロヘプテン、アミノテトラリン、アミノインダンおよびフェナルキルアミン誘導体、これらを含有する医薬組成物、および治療におけるこれらの使用
|
US8859584B2
(en)
|
2011-12-19 |
2014-10-14 |
Abbvie, Inc. |
TRPV1 antagonists
|
US8969325B2
(en)
|
2011-12-19 |
2015-03-03 |
Abbvie Inc. |
TRPV1 antagonists
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2013149376A1
(fr)
|
2012-04-02 |
2013-10-10 |
Abbott Laboratories |
Antagonistes de récepteurs de chimiokines
|
WO2013155695A1
(fr)
|
2012-04-20 |
2013-10-24 |
Abbott Laboratories |
Dérivés d'iso-indolone
|
CA2873075A1
(fr)
|
2012-05-11 |
2013-07-14 |
Abbvie Inc. |
Inhibiteurs de nampt
|
US8975398B2
(en)
|
2012-05-11 |
2015-03-10 |
Abbvie Inc. |
NAMPT inhibitors
|
US9193723B2
(en)
|
2012-05-11 |
2015-11-24 |
Abbvie Inc. |
NAMPT inhibitors
|
US9334264B2
(en)
|
2012-05-11 |
2016-05-10 |
Abbvie Inc. |
NAMPT inhibitors
|
US20130317055A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Neuronal nicotinic agonist and methods of use
|
US20130317054A1
(en)
|
2012-05-24 |
2013-11-28 |
Abbvie Inc. |
Neuronal nicotinic agonist and methods of use
|
CA2874953A1
(fr)
|
2012-06-12 |
2013-12-19 |
Abbvie Inc. |
Derives de pyridinone et de pyridazinone
|
US8796328B2
(en)
|
2012-06-20 |
2014-08-05 |
Abbvie Inc. |
TRPV1 antagonists
|
US20140080813A1
(en)
|
2012-09-14 |
2014-03-20 |
AbbVie Deutschland GmbH & Co. KG |
Tricyclic quinoline and quinoxaline derivatives
|
UA116216C2
(uk)
|
2012-09-14 |
2018-02-26 |
Еббві Дойчланд Гмбх Унд Ко. Кг |
Трициклічні хінолінові і хіноксалінові похідні
|
EP2970268A1
(fr)
|
2013-03-13 |
2016-01-20 |
AbbVie Inc. |
Inhibiteurs de la kinase cdk9
|
CN105189481A
(zh)
|
2013-03-13 |
2015-12-23 |
艾伯维公司 |
吡啶cdk9激酶抑制剂
|
WO2014160028A1
(fr)
|
2013-03-14 |
2014-10-02 |
Abbvie Inc. |
Inhibiteurs de pyrrolopyrimidine cdk9 kinase
|
MX2015012393A
(es)
|
2013-03-14 |
2016-04-28 |
Abbvie Deutschland |
Derivados oxindol con un sustituyente oxetano y uso de los mismos para tratar enfermedades relacionadas con la vasopresina.
|
WO2014139328A1
(fr)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Inhibiteurs de pyrrolo[2,3-b]pyridine cdk9 kinase
|
EP2970124B1
(fr)
|
2013-03-14 |
2019-05-22 |
The Board of Trustees of the Leland Stanford Junior University |
Modulateurs de l'aldéhyde déshydrogénase-2 mitochondriale et leurs procédés d'utilisation
|
MX2015012008A
(es)
|
2013-03-14 |
2016-04-15 |
Abbvie Deutschland |
Compuestos inhibidores novedosos de fosfodiesterasa tipo 10a.
|
AU2014231567A1
(en)
|
2013-03-14 |
2015-10-01 |
Abbvie Inc. |
Pyrrolo[2,3-b]pyridine CDK9 kinase inhibitors
|
US20140275082A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
US9650334B2
(en)
|
2013-03-15 |
2017-05-16 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9656955B2
(en)
|
2013-03-15 |
2017-05-23 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
JP2016533375A
(ja)
|
2013-10-17 |
2016-10-27 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
アミノテトラリン誘導体およびアミノインダン誘導体、これらを含有する医薬組成物、および治療におけるこれらの使用
|
AU2014336153A1
(en)
|
2013-10-17 |
2016-04-28 |
AbbVie Deutschland GmbH & Co. KG |
Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2015091931A1
(fr)
|
2013-12-20 |
2015-06-25 |
AbbVie Deutschland GmbH & Co. KG |
Dérivés d'oxindole à substituant azétidinyl substitué par pipéridyl, et leur utilisation pour le traitement de maladies liées à la vasopressine
|
WO2015119712A1
(fr)
|
2014-02-06 |
2015-08-13 |
Abbvie Inc. |
Inhibiteurs tétracycliques de la kinase cdk9
|
US9527856B2
(en)
|
2014-05-15 |
2016-12-27 |
AbbVie Deutschland GmbH & Co. KG |
Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases
|
EP3191459A1
(fr)
|
2014-09-05 |
2017-07-19 |
AbbVie Deutschland GmbH & Co. KG |
Composés hétérocycliques ou carbocycliques condensés portant un radical cycloaliphatique substitué et leur utilisation pour traiter les maladies liées à la vasopressine
|
US9550754B2
(en)
|
2014-09-11 |
2017-01-24 |
AbbVie Deutschland GmbH & Co. KG |
4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
|
CN104327004A
(zh)
*
|
2014-11-17 |
2015-02-04 |
重庆华邦制药有限公司 |
高纯度利奈唑胺氮氧化物的制备方法
|
WO2016160938A1
(fr)
|
2015-04-02 |
2016-10-06 |
Abbvie Inc. |
N-(1,3-thiazol-2-yl) pyrimidine-5-carboxamides en tant que modulateurs de trpv3
|
US20180339996A1
(en)
|
2015-11-25 |
2018-11-29 |
AbbVie Deutschland GmbH & Co. KG |
Hexahydropyrazinobenz- or -pyrido-oxazepines carrying an oxygen-containing substituent and use thereof in the treatment of 5-ht2c-dependent disorders
|
US10835535B2
(en)
|
2016-05-07 |
2020-11-17 |
Shanghai Fochon Pharmaceutical Co., Ltd. |
Certain protein kinase inhibitors
|
US11168078B2
(en)
|
2016-11-28 |
2021-11-09 |
Shanghai Fochon Pharmaceutical Co., Ltd. |
Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase
|
US9859219B1
(en)
|
2017-01-24 |
2018-01-02 |
International Business Machines Corporation |
Copper wiring structures with copper titanium encapsulation
|
US20200039930A1
(en)
|
2017-03-21 |
2020-02-06 |
AbbVie Deutschland GmbH & Co. KG |
Proline amide compounds and their azetidine analogues carrying a specifically substituted benzyl radical
|
JP7085566B2
(ja)
|
2017-04-18 |
2022-06-16 |
シャンハイ フォチョン ファーマシューティカル カンパニー リミテッド |
アポトーシス誘発剤
|
JP7294677B2
(ja)
|
2018-03-14 |
2023-06-20 |
フォチョン・ファーマシューティカルズ・リミテッド |
TRKキナーゼ阻害剤としての置換(2-アザビシクロ[3.1.0]ヘキサン-2-イル)ピラゾロ[1,5-a]ピリミジン化合物及び置換(2-アザビシクロ[3.1.0]ヘキサン-2-イル)イミダゾ[1,2-b]ピリダジン化合物
|
WO2019179525A1
(fr)
|
2018-03-23 |
2019-09-26 |
Fochon Pharmaceuticals, Ltd. |
Composés deutérés utilisés en tant qu'inhibiteurs de rock
|
WO2020234636A1
(fr)
|
2019-05-17 |
2020-11-26 |
Cadila Healthcare Limited |
Nouveaux composés pour le traitement d'infections de mammifères
|
US11608320B2
(en)
|
2020-02-02 |
2023-03-21 |
Kuwait University |
Oxazolidinone hydroxamic acid derivatives
|